Literature DB >> 10882741

Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3.

T Miller1, K Williams, R W Johnstone, A Shilatifard.   

Abstract

The human ELL gene, which is a frequent target for translocation in acute myeloid leukemia, was initially isolated from rat liver nuclei and found to be an RNA polymerase II elongation factor. Based on homology to ELL, we later cloned ELL2 and demonstrated that it can also increase the catalytic rate of transcription elongation by RNA polymerase II. To better understand the role of ELL proteins in the regulation of transcription by RNA polymerase II, we have initiated a search for proteins related to ELLs. In this report, we describe the molecular cloning, expression, and characterization of ELL3, a novel RNA polymerase II elongation factor approximately 50% similar to both ELL and ELL2. Our transcriptional studies have demonstrated that ELL3 can also increase the catalytic rate of transcription elongation by RNA polymerase II. The C-terminal domain of ELL, which we recently demonstrated to be required and sufficient for the immortalization of myeloid progenitor cells, shares strong similarities to the C-terminal domain of ELL3. ELL3 was localized by immunofluorescence to the nucleus of cells, and Northern analysis indicated that ELL3 is a testis-specific RNA polymerase II elongation factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882741     DOI: 10.1074/jbc.M005175200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.

Authors:  R W Johnstone; M Gerber; T Landewe; A Tollefson; W S Wold; A Shilatifard
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 3.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

4.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

Review 5.  Transcriptional elongation checkpoint control in development and disease.

Authors:  Edwin Smith; Ali Shilatifard
Journal:  Genes Dev       Date:  2013-05-15       Impact factor: 11.361

6.  Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.

Authors:  Liquan Cai; Binh L Phong; Alfred L Fisher; Zhou Wang
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 7.  Transcriptional and epigenetic regulation of B cell development.

Authors:  Patricia Santos; Fortuna Arumemi; Kyung Soo Park; Lisa Borghesi; Christine Milcarek
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

8.  Mutational analysis of an RNA polymerase II elongation factor in Drosophila melanogaster.

Authors:  Mark A Gerber; Ali Shilatifard; Joel C Eissenberg
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

10.  Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing.

Authors:  Kathleen Martincic; Serkan A Alkan; Alys Cheatle; Lisa Borghesi; Christine Milcarek
Journal:  Nat Immunol       Date:  2009-09-13       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.